Alan W. Stitt
Corresponding author: Alan W. Stitt
Name/email consistency: high
- Intervention with an erythropoietin-derived Peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. McVicar, C.M., Hamilton, R., Colhoun, L.M., Gardiner, T.A., Brines, M., Cerami, A., Stitt, A.W. Diabetes (2011)
- A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. Bhatwadekar, A., Glenn, J.V., Figarola, J.L., Scott, S., Gardiner, T.A., Rahbar, S., Stitt, A.W. Br. J. Ophthalmol (2008)
- Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Stitt, A.W., McGoldrick, C., Rice-McCaldin, A., McCance, D.R., Glenn, J.V., Hsu, D.K., Liu, F.T., Thorpe, S.R., Gardiner, T.A. Diabetes (2005)
- The maillard reaction in eye diseases. Stitt, A.W. Ann. N. Y. Acad. Sci. (2005)
- Advanced glycation and retinal pathology during diabetes. Stitt, A.W., Curtis, T.M. Pharmacol. Rep (2005)
- Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina. Stitt, A.W., Graham, D., Gardiner, T.A. Mol. Vis. (2004)
- Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Stitt, A.W., Hughes, S.J., Canning, P., Lynch, O., Cox, O., Frizzell, N., Thorpe, S.R., Cotter, T.G., Curtis, T.M., Gardiner, T.A. Diabetologia (2004)
- The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Stitt, A., Gardiner, T.A., Alderson, N.L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A.S., Chachich, M., Baynes, J.W., Thorpe, S.R., Anderson, N.L. Diabetes (2002)
- Advanced glycation: an important pathological event in diabetic and age related ocular disease. Stitt, A.W. Br. J. Ophthalmol (2001)
- Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains. Stitt, A.W., Burke, G.A., Chen, F., McMullen, C.B., Vlassara, H. FASEB J. (2000)
- Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. Stitt, A.W., He, C., Vlassara, H. Biochem. Biophys. Res. Commun. (1999)
- Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours. Stitt, A.W., Simpson, D.A., Boocock, C., Gardiner, T.A., Murphy, G.M., Archer, D.B. J. Pathol. (1998)
- The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy. Stitt, A.W., McKenna, D., Simpson, D.A., Gardiner, T.A., Harriott, P., Archer, D.B., Nelson, J. Am. J. Pathol. (1998)